Lamark is poised to become a global pioneer in breaking cold chain dependence for Insulin. We are a biotechnology company focused on R&D that develops thermostable Biologics, which are multifold stable formulations of existing biologics. We have generated proof of concept analytical and preclinical data with our proprietary technology (patent filed) for rHI. The technology is being used for 4 other proteins under development with our collaborators. Our team is working in collaboration with pharma companies, academic laboratories, and government agencies to create thermostable and cost- effective biologics.